Experimental evaluation of anticonvulsant effect of human placental extract in pentylenetetrazole induced convulsions in mice

Avanthi S., Pushpalatha Chinnam, Gundappa S. Rao, Sam Pavan Kumar G., Mohd. Mohsin

Abstract


Background: Human placental extract (HPE) is used in different clinical conditions. Human placental extract (HPE), a folklore medicine, prepared from fresh, healthy human placenta has been in use, as single dose therapy in the treatment of epilepsy in some parts of India. Hence, present study was carried out to explore anticonvulsant property of Human placental extract (HPE) in Pentylenetetrazole (PTZ) induced convulsions in albino mice.

Methods: Effects of human placental extract (HPE) (1.0, 1.2 and 1.4 ml / 100 gm body weight) as test drug, sodium valproate (150 mg / kg body weight) as standard and distilled water as control were studied in pentylenetetrazole (PTZ) induced convulsions in albino mouse model. Failure to observe even a single episode of tonic spasm for 5 sec. duration for 1 hour was taken as index of anticonvulsant activity. Onset, duration, complete recovery from convulsion and percent protection was calculated and statistical analysis was carried out using student ‘t’ test.

Results: Pretreatment with human placental extract (HPE) administered in the dose of 1.0 ml / 100 gm body weight provided 33.33% and in the doses of 1.2 and 1.4 ml / 100 gm body weight and sodium valproate provided 100% protection from convulsions induced by Pentylenetetrazole in albino mice.

Conclusion: Human placental extract (HPE) has shown promising anticonvulsant effect on Pentylenetetrazole induced mouse model.


Keywords


Anticonvulsant, Human placental extract (HPE), Sodium valproate, Pentylenetetrazole

Full Text:

PDF

References


James O. McNamara. Pharmacotherapy of the Epilepsies. In: Laurence L. Brunton, Bruce A. Chabner, Bjorn C. Knollmann, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011: 583-607.

Bharucha NE. Epidemiology of epilepsy in India. Epilepsia 2003; 44: 9-11.

Gourie-Devi M, Gururaj G, Sathishchandra P, Subbakrishna DK. Prevalence of neurological disorders in Bangalore, India: A community-based study with a comparison between urban and rural areas. Neuroepidemiology 2004; 23: 261-8.

Roger J. Porter, Brian S. Meldrum. Anti-seizure drugs. In: Bertram G. Katzung, eds. Basic and Clinical Pharmacology. 11th Edn. New Delhi, Tata McGraw-Hill Education Private Limeted; 2009: 399-422.

Brodie M.J., Dichter M. Anti-convulsant drugs. N. Engl. J. Med. 1996; 334: 168-175.

Liao WP, Chen L, Yi YH, Sun WW, Gao MM, Su T, et al. Study of antiepileptic effect of extracts from Aconus tatarinowii Schott. Epilepsia 2005; 46: 214.

Piyali Datta Chakraborty and Debsish Bhattacharya (2012). Aqueous Extract of Human Placenta, Recent Advances in Research on the Human Placenta, Dr. Jing Zheng (Ed.), ISBN: 978-953-51-01949, InTech, Available from: http://www.intechopen.com/books/ recent-advances-in-research-on-the-human-placenta/ aqueous-extract-of-human-placenta-as-a-therapeutic-agent.

Shibasaki T, Odagiri E, Shizume K, Ling N. Corticotropin-releasing factor like activity in human placental extracts. J Clin Endocrinol Metab 1982; 55: 384-6.

H. Gerhard Vogel, Wolfgang H. Vogel, Berhard Ascholkens, Jurgen Sandow, Gunter Muller, Wolfgang F. Vogel. Drug Discovery and Evaluation, 2nd Edn, Springer Verlag, Berlin, Heidelberg, 2002:422.

Sur T. K. et al. Anti-inflammatory and anti-platelet aggregation activity of human placental extract. Acta Pharmacol Sin, 2003 Feb. 24(2) 187-192.

Joseph S, David J, Joseph T. Additive anticonvulsant effect of flunarizine and sodium valproate on electroshock and chemoshock induced convulsions in mice. Indian J Physiol Pharmacol 1998;42:383-8.

Ashish K. Rehni, Nirmal Singh. Reversal of pentylenetetrazole – induced seizure activity in mice by Nickel Chloride. Indian J. Pharmacol 2009;41:15-8.

Loscher W, Honack D, Fassbender CP, Nolling B. The role of technical, biological and pharmacological factors in the laboratory evaluationof anticonvulsant drugs. III: Pentylenetetrazole seizure models. Epilepsy Res 1991; 8: 171-189.

Starzl TE, Niemer WT, Dell M, Forgave PR. Cortical and subcortical electrical activity in experimental seizures induced by metrazole. J Neuropath Exp Neurol 1953; 12: 262-76.

Ramanjaneyulu R, Ticku MK. Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine- GABA receptor-ionophore complex. Eur J Pharmacol 1984;98:337-45.

Papp A, Feher O, et al. The ionic mechanism of the pentylenetetrazole convulsions. Acta Biol Hung 1987;38(3-4):349-61.

Erakovic´ V, Zupan G, Varljen J, Simonic´. A Pentylenetetrazole-induced seizures and kindling: changes in free fatty acids, superoxide dismutase, and glutathione peroxidase activity. Neurochem Int 2003;42:173-8.

Akbas SH, Yegin A, Ozben T. Effect of pentylenetetrazole induced epileptic seizure on the antioxidant enzyme activities, glutathione and lipid peroxidation levels in rat erythrocytes and liver tissues. Clin Biochem 2005;38:1009-14.

Armag˘an M, Kutluhan S, Yılmaz M, Yılmaz N, Bu¨lbu¨l M, Vural H, et al. Topiramate and vitamin E modulates antioxidant enzymes, nitric oxide and lipid peroxidation in pentylentetrazole-induced nephrotoxicity in rats. Basic Clin Pharm Toxicol 2008;103:166-70.

Frantseva MV, Perez Velazquez JL, Tsoraklidis G, Mendonca AJ, Adamchik Y, Mills LR, et al. Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy. Neuroscience 2000;97:431-5.

Deniz Onay B, Tasdemir E, Tu¨mer C, Bilgin HM, Atmaca M. Dose dependent effects of ghrelin on pentylenetetrazole induced oxidative stress in a rat seizure model. Peptides 2008;29:448-55.

Shinde V, Dhalwal K, Paradkar AR, Mahadik KR, Kadam SS. Evaluation of in-vitro antioxidant activity of human placental extract. Pharmacology online 2006;3:172-9.